Renuva Anti-Aging Formulas

Prentice-Lewis Clinical Research Study
Continued from previous page

The following is the average overall improvement for all subjects for all 37-health categories. A total score for each health area for all 63 subjects was compared to the baseline total score in order to establish the % improvement over time.

When the data was assessed based on the average overall % improvement score for each time category (baseline, 1 week, 1 month, 2 months, 3 or more months), the results indicate that subjects perceived a steady improvement in overall health with continued use of the product.

The following shows the percent change of the ratings as a series of data points (1 through 7) all held to be of equal significance:

The trend shows that subjects showed significant improvement in their overall health assessment over time.

The following graph summarizes the total number of responses for each category (1-7) for: (1) all baseline responses; and (2) for all final survey responses. All Baseline responses are in white and final responses in gray.

Four of the 63 subjects (6%) claimed that the proprietary micro-dilution oral spray Growth Factor-MMC system helped them in all 37 areas.

Survey subjects who noted a positive improvement in overall quality of life self-scored positive benefits in an average of 18.3 different areas out of the 37 areas surveyed (49.8%).

Continued on next page

S T U D I E S


	The Renuva Clinical Study

	The Prentice and Lewis Study